Wendy future of retail top

Thomas Menighan

Patient safety key as NACDS and APhA oppose prescription drug importation

Patient safety key as NACDS and APhA oppose prescription drug importation

ARLINGTON, Va. — The National Association of Chain Drug Stores (NACDS) and the American Pharmacists Association (APhA) expressed concerns about the risks to patient health and the security of the prescription drug supply chain in opposing legislation that would allow for personal and commercial importation of prescription drugs outside of the Food and Drug Administration’s (FDA)

Pharmacy HIT Collaborative releases revised strategic plan

Pharmacy HIT Collaborative releases revised strategic plan

ALEXANDRIA, Va. — The Pharmacy HIT Collaborative today released its revised strategic plan: The Roadmap for Pharmacy Information Technology Integration in U.S. Health Care: 2018 to 2021 Update. “This third roadmap is an important achievement,” said Kurt Proctor, chairman, PHIT Collaborative and senior vice president, Strategic Initiatives, National Community Pharmacist Association. “The PHIT Collaborative is

NACDS among group joining in fight against opioid abuse

NACDS among group joining in fight against opioid abuse

WASHINGTON—  Opioid abuse is a serious public health problem that has reached crisis levels across the United States, with more than 90 Americans dying each day from overdose of opioids, and many more becoming addicted. Recognizing the urgency and impact of this issue on the health of millions of patients across the country, a coalition

APhA launches Leadership360 Institute

APhA launches Leadership360 Institute

WASHINGTON — The American Pharmacists Association (APhA) has unveiled the Leadership360 Institute, an educational program to help pharmacists enhance their leadership and management skills. Institute participants can sign up for any or all of the three Leadership tracks, including Lead360, Mentor360 and Manage360. Each track will offer programs to help pharmacists excel in their individual

Provider status bill returns to House

Provider status bill returns to House

WASHINGTON — Just about a week after being reintroduced in the Senate, the pharmacy provider status bill is now once again before the House of Representatives. Reps. Brett Guthrie (R., Ky.), G.K. Butterfield (D., N.C.), Ron Kind (D., Wis.) and Tom Reed (R., N.Y.) on Friday introduced the Pharmacy and Medically Underserved Areas Enhancement Act

Pharmacist provider status bill back in play

Pharmacist provider status bill back in play

WASHINGTON – Pharmacist provider status legislation is back before Congress, with the bipartisan co-sponsorship of more than a quarter of the Senate. Sens. Chuck Grassley (R., Iowa), Bob Casey (D., Penn.) and Sherrod Brown (D., Ohio) on Thursday reintroduced the Pharmacy and Medically Underserved Areas Enhancement Act (S. 109) with its 27 original co-sponsors. A

Diplomat video series talks specialty pharmacy

Diplomat video series talks specialty pharmacy

FLINT, Mich. — Diplomat Pharmacy Inc. is launching a video Q&A series highlighting the role of specialty pharmacy and how it works with physicians to support patients with complex chronic conditions. Called “Diplomat Dialogues,” the video conversations — in recognition of American Pharmacists Month — will feature industry leaders discussing specialty pharmacists’ skill set and

APhA hails lawmakers’ support of provider status bill

APhA hails lawmakers’ support of provider status bill

WASHINGTON — The American Pharmacists Association (APhA) applauded remarks by two congressmen in support of pharmacist provider status legislation. APhA said Reps. Ron Kind (D., Wis.) and Todd Young (R., Ind.) issued statements this week to the House Ways and Means Subcommittee on Health calling for pharmacists to have a bigger role in health care.

Drug chains step up, do their part to curb Rx abuse

NEW YORK — Drug chains are spearheading efforts to fight prescription drug abuse through a range of initiatives. CVS Health reported that its Medication Disposal for Safer Communities program has donated more than 500 drug collection units to law enforcement partners across the U.S. The donation resulted in the safe disposal of more than 35

Walgreens, APhA take aim at substance abuse

Walgreens, APhA take aim at substance abuse

WASHINGTON — Walgreens has teamed up with the American Pharmacists Association (APhA) to battle prescription drug abuse. Through the collaboration, the APhA Institute on Alcoholism and Drug Dependencies will continue to offer a substance abuse education program for pharmacists and student pharmacists. The four-day educational program, which will provide pharmacy professionals with key information and

Provider status bill builds momentum

Provider status bill builds momentum

WASHINGTON — Congressional support continues to mount for the pharmacy industry’s push for pharmacists to be designated as health care providers. The American Pharmacists Association (APhA) reported that a majority of the U.S. House of Representatives now support the Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 592), or the so-called provider status bill. Overall,

APhA COO appointed interim executive director of APhA Foundation

APhA COO appointed interim executive director of APhA Foundation

WASHINGTON — Elizabeth Keyes, chief operating officer of the American Pharmacists Association (APhA), has been named as interim executive director of the APhA Foundation with the departure of Mindy Smith. APhA said this week that Smith is joining the executive team at PrescribeWellness, a provider of community pharmacy and patient care solutions. Keyes is slated

Pharmacy groups ask FDA to delay product tracing deadline

Pharmacy groups ask FDA to delay product tracing deadline

ALEXANDRIA, Va. — The National Community Pharmacists Association (NCPA), American Pharmacists Association (APhA) and National Alliance of State Pharmacy Associations (NASPA) have asked the Food and Drug Administration to delay enforcement of a July 1 product tracing deadline for dispensers of pharmaceuticals. In a letter this week to the FDA’s Office of Compliance, the three

Centrum 7/6  banner